Health / Medical Topics |
CDK4 Inhibitor P1446A-05
A protein kinase inhibitor specific for the cyclin-dependent kinase 4 (CDK4) with potential antineoplastic activity. CDK4 inhibitor P1446A-05 specifically inhibits CDK4-mediated G1-S phase transition, arresting cell cycling and inhibiting cancer cell growth. The serine/threonine kinase CDK4 is found in a complex with D-type G1 cyclins and is the first kinase to become activated upon mitogenic stimulation, releasing cells from a quiescent stage into the G1/S growth cycling stage; CDK-cyclin complexes have been shown to phosphorylate the retinoblastoma (Rb) transcription factor in early G1, displacing histone deacetylase (HDAC) and blocking transcriptional repression. (NCI Thesaurus)
YOU MAY ALSO LIKE
This gene is involved in G1 stage cell cycle progression.
Human CDK3 wild-type allele is located within 17q22-qter and is approximately 27 kb in length. This allele, which encodes cyclin-dependent kinase 3…
This gene is involved in cell cycle checkpoints.
Human CDK2AP2 wild-type allele is located within 11q13 and is approximately 2 kb in length. This allele, which encodes cyclin-dependent kinase 2-associated…
This gene plays a regulatory role in cell cycle events.
Human CDK2AP1 wild-type allele is located in the vicinity of 12q24.31 and is approximately 4 kb in length. This allele, which encodes…